| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alphapapillomavirus | 3 | 2022 | 221 | 1.490 |
Why?
|
| Uterine Cervical Dysplasia | 2 | 2022 | 387 | 1.250 |
Why?
|
| Uterine Cervical Neoplasms | 5 | 2022 | 2020 | 0.890 |
Why?
|
| Papillomavirus Vaccines | 2 | 2022 | 491 | 0.630 |
Why?
|
| Boron Neutron Capture Therapy | 7 | 2004 | 51 | 0.610 |
Why?
|
| Radiation Dosage | 4 | 2018 | 1928 | 0.600 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 9 | 2014 | 1624 | 0.600 |
Why?
|
| Water | 2 | 2020 | 1395 | 0.560 |
Why?
|
| Radiometry | 7 | 2011 | 800 | 0.520 |
Why?
|
| Tomography, X-Ray Computed | 13 | 2020 | 20129 | 0.520 |
Why?
|
| Phantoms, Imaging | 8 | 2021 | 2480 | 0.480 |
Why?
|
| Papillomavirus Infections | 2 | 2022 | 1587 | 0.460 |
Why?
|
| Cerebrospinal Fluid | 2 | 2007 | 534 | 0.450 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 2 | 2010 | 105 | 0.430 |
Why?
|
| Technetium Tc 99m Mertiatide | 1 | 2011 | 22 | 0.410 |
Why?
|
| Breast | 1 | 2021 | 1969 | 0.400 |
Why?
|
| Body Burden | 1 | 2011 | 158 | 0.390 |
Why?
|
| Japan | 3 | 2022 | 1360 | 0.340 |
Why?
|
| Respiratory-Gated Imaging Techniques | 1 | 2009 | 71 | 0.340 |
Why?
|
| Radiotherapy, Conformal | 1 | 2011 | 548 | 0.310 |
Why?
|
| Papillomaviridae | 3 | 2022 | 1119 | 0.300 |
Why?
|
| Calibration | 2 | 2020 | 816 | 0.280 |
Why?
|
| Fluorescence | 2 | 2007 | 751 | 0.280 |
Why?
|
| Boron | 5 | 2004 | 36 | 0.280 |
Why?
|
| Radionuclide Imaging | 1 | 2010 | 2031 | 0.280 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2009 | 266 | 0.280 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2011 | 1107 | 0.270 |
Why?
|
| Positron-Emission Tomography | 8 | 2012 | 6234 | 0.270 |
Why?
|
| Age Distribution | 2 | 2022 | 2902 | 0.270 |
Why?
|
| Fructose | 2 | 2004 | 288 | 0.260 |
Why?
|
| Models, Biological | 3 | 2018 | 9583 | 0.240 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2007 | 721 | 0.230 |
Why?
|
| Liver Transplantation | 2 | 2012 | 2119 | 0.230 |
Why?
|
| Neutron Capture Therapy | 1 | 2002 | 6 | 0.220 |
Why?
|
| Vaccines, Combined | 1 | 2022 | 69 | 0.210 |
Why?
|
| Hydrocephalus | 1 | 2007 | 748 | 0.190 |
Why?
|
| Platelet-Rich Plasma | 2 | 2015 | 177 | 0.180 |
Why?
|
| Electromagnetic Phenomena | 1 | 2020 | 161 | 0.180 |
Why?
|
| Kidney Transplantation | 2 | 2012 | 4251 | 0.170 |
Why?
|
| Hand | 2 | 2023 | 884 | 0.170 |
Why?
|
| Radiopharmaceuticals | 6 | 2012 | 2645 | 0.170 |
Why?
|
| Radial Artery | 1 | 2020 | 194 | 0.170 |
Why?
|
| Kidney | 2 | 2012 | 7186 | 0.170 |
Why?
|
| Antibodies, Monoclonal | 3 | 2010 | 9274 | 0.160 |
Why?
|
| Glioblastoma | 6 | 2004 | 3481 | 0.150 |
Why?
|
| Radiotherapy Dosage | 10 | 2014 | 2879 | 0.150 |
Why?
|
| Iohexol | 1 | 2018 | 196 | 0.150 |
Why?
|
| Boron Compounds | 3 | 2004 | 178 | 0.150 |
Why?
|
| Motor Skills | 1 | 2020 | 522 | 0.150 |
Why?
|
| Fluorodeoxyglucose F18 | 3 | 2012 | 2016 | 0.150 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2018 | 168 | 0.150 |
Why?
|
| Hypothalamic Area, Lateral | 1 | 2018 | 104 | 0.150 |
Why?
|
| Catheterization, Peripheral | 1 | 2020 | 345 | 0.150 |
Why?
|
| Genotype | 2 | 2022 | 12951 | 0.150 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2011 | 8949 | 0.150 |
Why?
|
| Adipose Tissue, Brown | 2 | 2013 | 757 | 0.140 |
Why?
|
| Benchmarking | 1 | 2023 | 1042 | 0.140 |
Why?
|
| Radiotherapy, Intensity-Modulated | 2 | 2014 | 806 | 0.140 |
Why?
|
| Yttrium Radioisotopes | 2 | 2007 | 93 | 0.140 |
Why?
|
| Meta-Analysis as Topic | 1 | 2021 | 1344 | 0.140 |
Why?
|
| Breast Neoplasms | 2 | 2021 | 20822 | 0.140 |
Why?
|
| Brain Neoplasms | 6 | 2004 | 8863 | 0.140 |
Why?
|
| Biopsy, Needle | 1 | 2021 | 1641 | 0.130 |
Why?
|
| Prevalence | 2 | 2022 | 15226 | 0.130 |
Why?
|
| Indocyanine Green | 2 | 2007 | 239 | 0.120 |
Why?
|
| Optics and Photonics | 2 | 2007 | 321 | 0.120 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2021 | 4042 | 0.120 |
Why?
|
| Organs at Risk | 2 | 2014 | 346 | 0.110 |
Why?
|
| Radiography, Interventional | 1 | 2020 | 1095 | 0.110 |
Why?
|
| Esophageal Neoplasms | 2 | 2013 | 1583 | 0.110 |
Why?
|
| Sympathomimetics | 1 | 2012 | 57 | 0.110 |
Why?
|
| Diagnostic Imaging | 1 | 2007 | 3507 | 0.110 |
Why?
|
| Brain | 5 | 2018 | 26385 | 0.100 |
Why?
|
| Cold Temperature | 2 | 2013 | 772 | 0.100 |
Why?
|
| Body Temperature Regulation | 1 | 2013 | 252 | 0.100 |
Why?
|
| Chondrosarcoma | 1 | 2014 | 309 | 0.100 |
Why?
|
| Rotator Cuff | 1 | 2015 | 326 | 0.100 |
Why?
|
| Neutrons | 2 | 2002 | 76 | 0.100 |
Why?
|
| Radioisotopes | 2 | 2010 | 499 | 0.100 |
Why?
|
| Chordoma | 1 | 2014 | 359 | 0.100 |
Why?
|
| Humans | 43 | 2023 | 744343 | 0.100 |
Why?
|
| Skull Base Neoplasms | 1 | 2014 | 284 | 0.090 |
Why?
|
| Early Detection of Cancer | 2 | 2022 | 3086 | 0.090 |
Why?
|
| Radiation Injuries | 4 | 2014 | 1180 | 0.090 |
Why?
|
| Mice, Nude | 2 | 2007 | 3689 | 0.090 |
Why?
|
| Sensitivity and Specificity | 5 | 2013 | 14722 | 0.090 |
Why?
|
| Software | 2 | 2018 | 4443 | 0.090 |
Why?
|
| Image Interpretation, Computer-Assisted | 4 | 2013 | 3327 | 0.080 |
Why?
|
| Clinical Competence | 2 | 2023 | 4687 | 0.080 |
Why?
|
| Epinephrine | 1 | 2012 | 792 | 0.080 |
Why?
|
| Ependymoma | 1 | 2012 | 334 | 0.080 |
Why?
|
| Female | 26 | 2022 | 380194 | 0.080 |
Why?
|
| Arthroscopy | 1 | 2015 | 926 | 0.080 |
Why?
|
| DNA | 1 | 2022 | 7301 | 0.080 |
Why?
|
| Statistics, Nonparametric | 2 | 2013 | 2886 | 0.080 |
Why?
|
| Linear Models | 1 | 2018 | 5952 | 0.080 |
Why?
|
| Germanium | 1 | 2007 | 7 | 0.080 |
Why?
|
| Photons | 1 | 2011 | 588 | 0.070 |
Why?
|
| Mammography | 1 | 2018 | 2476 | 0.070 |
Why?
|
| Arteritis | 1 | 2009 | 159 | 0.070 |
Why?
|
| Gallium Radioisotopes | 1 | 2007 | 178 | 0.070 |
Why?
|
| Neoplasms | 3 | 2011 | 21683 | 0.070 |
Why?
|
| Subarachnoid Space | 1 | 2005 | 79 | 0.070 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2009 | 415 | 0.070 |
Why?
|
| Health Expenditures | 1 | 2018 | 2348 | 0.070 |
Why?
|
| Fast Neutrons | 1 | 2004 | 18 | 0.060 |
Why?
|
| Contrast Media | 1 | 2018 | 5300 | 0.060 |
Why?
|
| Spinal Neoplasms | 1 | 2012 | 760 | 0.060 |
Why?
|
| Cerebral Ventricles | 1 | 2007 | 544 | 0.060 |
Why?
|
| Monte Carlo Method | 3 | 2004 | 1254 | 0.060 |
Why?
|
| Colon | 1 | 2012 | 1772 | 0.060 |
Why?
|
| Least-Squares Analysis | 1 | 2004 | 379 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 13989 | 0.060 |
Why?
|
| Immobilization | 1 | 2004 | 236 | 0.060 |
Why?
|
| Adiposity | 1 | 2013 | 1807 | 0.060 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2007 | 644 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2023 | 5788 | 0.050 |
Why?
|
| Melanoma | 5 | 2004 | 5510 | 0.050 |
Why?
|
| Radiology Information Systems | 1 | 2007 | 523 | 0.050 |
Why?
|
| Middle Aged | 17 | 2022 | 213383 | 0.050 |
Why?
|
| Wound Healing | 2 | 2015 | 2785 | 0.050 |
Why?
|
| Models, Theoretical | 4 | 2003 | 3589 | 0.050 |
Why?
|
| Image Enhancement | 3 | 2009 | 2921 | 0.050 |
Why?
|
| Adult | 18 | 2022 | 214055 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 5391 | 0.050 |
Why?
|
| Aged | 12 | 2018 | 163280 | 0.050 |
Why?
|
| Lymphatic Metastasis | 1 | 2009 | 2924 | 0.050 |
Why?
|
| Joint Instability | 1 | 2009 | 792 | 0.050 |
Why?
|
| Information Storage and Retrieval | 1 | 2007 | 824 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 2 | 2006 | 2699 | 0.050 |
Why?
|
| Lipoproteins, HDL | 1 | 2005 | 638 | 0.050 |
Why?
|
| Maximum Tolerated Dose | 1 | 2003 | 892 | 0.050 |
Why?
|
| User-Computer Interface | 1 | 2007 | 1431 | 0.050 |
Why?
|
| Posture | 1 | 2004 | 958 | 0.050 |
Why?
|
| Rectum | 1 | 2005 | 904 | 0.050 |
Why?
|
| Male | 20 | 2018 | 350118 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 25043 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2010 | 2635 | 0.040 |
Why?
|
| Vaccination | 2 | 2022 | 3278 | 0.040 |
Why?
|
| Pilot Projects | 4 | 2020 | 8324 | 0.040 |
Why?
|
| Phenylalanine | 1 | 2001 | 365 | 0.040 |
Why?
|
| Punctures | 1 | 2020 | 374 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2013 | 19905 | 0.040 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2006 | 808 | 0.040 |
Why?
|
| Myanmar | 1 | 2018 | 45 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2005 | 1172 | 0.040 |
Why?
|
| Vesicular Inhibitory Amino Acid Transport Proteins | 1 | 2018 | 45 | 0.040 |
Why?
|
| Adenocarcinoma | 2 | 2013 | 6364 | 0.040 |
Why?
|
| Muscarinic Agonists | 1 | 2018 | 87 | 0.040 |
Why?
|
| Dynorphins | 1 | 2018 | 84 | 0.040 |
Why?
|
| Carbachol | 1 | 2018 | 226 | 0.040 |
Why?
|
| Parasympathetic Nervous System | 1 | 2018 | 141 | 0.040 |
Why?
|
| Predictive Value of Tests | 3 | 2012 | 15076 | 0.040 |
Why?
|
| Prospective Studies | 5 | 2020 | 53288 | 0.040 |
Why?
|
| Young Adult | 4 | 2022 | 56430 | 0.040 |
Why?
|
| Brachytherapy | 1 | 2005 | 1248 | 0.040 |
Why?
|
| Tetrodotoxin | 1 | 2018 | 259 | 0.040 |
Why?
|
| Radioimmunotherapy | 2 | 2007 | 91 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2020 | 5078 | 0.040 |
Why?
|
| Protons | 2 | 2012 | 1127 | 0.030 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2018 | 377 | 0.030 |
Why?
|
| Retrospective Studies | 6 | 2022 | 77449 | 0.030 |
Why?
|
| Multiple Sclerosis | 4 | 1993 | 3079 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2023 | 1486 | 0.030 |
Why?
|
| Tomography, Emission-Computed | 2 | 1989 | 1144 | 0.030 |
Why?
|
| Time Factors | 3 | 2020 | 40075 | 0.030 |
Why?
|
| Nuclear Medicine | 2 | 2007 | 233 | 0.030 |
Why?
|
| Animals | 9 | 2018 | 168757 | 0.030 |
Why?
|
| Receptors, GABA-A | 1 | 2018 | 627 | 0.030 |
Why?
|
| Family Characteristics | 1 | 2018 | 1000 | 0.030 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2006 | 2245 | 0.030 |
Why?
|
| Health Services | 1 | 2018 | 758 | 0.030 |
Why?
|
| Relative Biological Effectiveness | 1 | 2014 | 323 | 0.030 |
Why?
|
| Mice | 3 | 2018 | 81183 | 0.030 |
Why?
|
| Intestine, Large | 1 | 2012 | 71 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2010 | 5221 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2013 | 35421 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2018 | 2025 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2013 | 15295 | 0.020 |
Why?
|
| Radiobiology | 2 | 2001 | 85 | 0.020 |
Why?
|
| Treatment Outcome | 6 | 2015 | 63114 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2003 | 876 | 0.020 |
Why?
|
| Erythema | 1 | 2012 | 257 | 0.020 |
Why?
|
| Ions | 2 | 2001 | 265 | 0.020 |
Why?
|
| Biophysical Phenomena | 2 | 2001 | 327 | 0.020 |
Why?
|
| Biophysics | 2 | 2001 | 383 | 0.020 |
Why?
|
| Dihydroxyphenylalanine | 1 | 1989 | 76 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2023 | 5985 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2009 | 6487 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 1993 | 895 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2012 | 57776 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2015 | 1683 | 0.020 |
Why?
|
| Organ Size | 1 | 2013 | 2252 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 18029 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2012 | 2327 | 0.020 |
Why?
|
| Substantia Nigra | 1 | 1989 | 353 | 0.020 |
Why?
|
| Cyclazocine | 1 | 1986 | 10 | 0.020 |
Why?
|
| Thermoluminescent Dosimetry | 1 | 2007 | 24 | 0.020 |
Why?
|
| Prefrontal Cortex | 1 | 2018 | 2147 | 0.020 |
Why?
|
| Phencyclidine | 1 | 1986 | 61 | 0.020 |
Why?
|
| Sutures | 1 | 2009 | 299 | 0.020 |
Why?
|
| Software Design | 1 | 2007 | 176 | 0.020 |
Why?
|
| Registries | 1 | 2022 | 8089 | 0.020 |
Why?
|
| Radiotherapy | 1 | 2013 | 1533 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 13102 | 0.020 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2009 | 262 | 0.020 |
Why?
|
| Interferon Type I | 1 | 1990 | 542 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2012 | 1915 | 0.020 |
Why?
|
| Pharmacies | 1 | 2007 | 150 | 0.020 |
Why?
|
| Database Management Systems | 1 | 2007 | 270 | 0.020 |
Why?
|
| Cesium Radioisotopes | 1 | 2005 | 36 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2006 | 399 | 0.020 |
Why?
|
| Recurrence | 2 | 2015 | 8340 | 0.020 |
Why?
|
| Reoperation | 1 | 2015 | 4201 | 0.020 |
Why?
|
| Computer Graphics | 1 | 2007 | 361 | 0.020 |
Why?
|
| Purkinje Cells | 1 | 1986 | 224 | 0.020 |
Why?
|
| Gastrointestinal Diseases | 1 | 2013 | 1170 | 0.020 |
Why?
|
| Quality Control | 1 | 2007 | 841 | 0.020 |
Why?
|
| Quantum Dots | 1 | 2006 | 172 | 0.020 |
Why?
|
| Fatigue | 1 | 2012 | 1531 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6365 | 0.020 |
Why?
|
| Algorithms | 1 | 2004 | 13881 | 0.010 |
Why?
|
| Body Size | 1 | 2007 | 461 | 0.010 |
Why?
|
| Reference Standards | 1 | 2007 | 1025 | 0.010 |
Why?
|
| Incidence | 1 | 2022 | 20947 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2006 | 813 | 0.010 |
Why?
|
| Corpus Striatum | 1 | 1989 | 1221 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2013 | 1886 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2012 | 9239 | 0.010 |
Why?
|
| Models, Animal | 1 | 2009 | 2171 | 0.010 |
Why?
|
| Heavy Ions | 1 | 2002 | 12 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2018 | 6669 | 0.010 |
Why?
|
| Alpha Particles | 1 | 2002 | 26 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2006 | 2085 | 0.010 |
Why?
|
| Half-Life | 1 | 2003 | 661 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2012 | 2925 | 0.010 |
Why?
|
| Cell Survival | 2 | 2002 | 5882 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 8642 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 6895 | 0.010 |
Why?
|
| Ambulatory Care Facilities | 1 | 2007 | 933 | 0.010 |
Why?
|
| Dietary Fats | 1 | 2009 | 2017 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2013 | 9849 | 0.010 |
Why?
|
| Linear Energy Transfer | 1 | 2001 | 154 | 0.010 |
Why?
|
| Aging | 2 | 2009 | 8664 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2013 | 2788 | 0.010 |
Why?
|
| Patient Selection | 1 | 2012 | 4215 | 0.010 |
Why?
|
| Adolescent | 2 | 2022 | 85781 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 2 | 1993 | 1681 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2022 | 40561 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 1987 | 1670 | 0.010 |
Why?
|
| Swine | 1 | 2009 | 5917 | 0.010 |
Why?
|
| Boston | 1 | 2012 | 9313 | 0.010 |
Why?
|
| Heart | 1 | 2012 | 4467 | 0.010 |
Why?
|
| CHO Cells | 1 | 2001 | 1406 | 0.010 |
Why?
|
| Artifacts | 1 | 2007 | 1904 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2006 | 6314 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2006 | 3616 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 4034 | 0.010 |
Why?
|
| Infant | 2 | 2012 | 35136 | 0.010 |
Why?
|
| Survival Rate | 1 | 2012 | 12788 | 0.010 |
Why?
|
| Cricetinae | 1 | 2001 | 2472 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2010 | 6196 | 0.010 |
Why?
|
| Pregnancy | 1 | 2018 | 29144 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2001 | 2274 | 0.010 |
Why?
|
| Myocardium | 1 | 2009 | 4776 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 7279 | 0.010 |
Why?
|
| Lung | 1 | 2012 | 9856 | 0.010 |
Why?
|
| Rats | 2 | 2006 | 24260 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 11524 | 0.010 |
Why?
|
| Skin Neoplasms | 2 | 2003 | 5686 | 0.010 |
Why?
|
| Psychotic Disorders | 1 | 1987 | 3046 | 0.010 |
Why?
|
| Child | 2 | 2012 | 77709 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2012 | 23338 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 39050 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2012 | 41006 | 0.010 |
Why?
|
| Receptors, Phencyclidine | 1 | 1986 | 13 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2007 | 25625 | 0.000 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1986 | 178 | 0.000 |
Why?
|
| Radiation | 1 | 1986 | 49 | 0.000 |
Why?
|
| Models, Structural | 1 | 1986 | 361 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1986 | 2186 | 0.000 |
Why?
|
| Risk Factors | 1 | 2012 | 72290 | 0.000 |
Why?
|
| Electrons | 1 | 1986 | 268 | 0.000 |
Why?
|
| Scattering, Radiation | 1 | 1986 | 498 | 0.000 |
Why?
|
| Naloxone | 1 | 1986 | 367 | 0.000 |
Why?
|
| Electrophysiology | 1 | 1986 | 1308 | 0.000 |
Why?
|
| Statistics as Topic | 1 | 1990 | 2373 | 0.000 |
Why?
|
| United States | 1 | 2007 | 69872 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1987 | 3760 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1990 | 12026 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1990 | 9959 | 0.000 |
Why?
|
| Neurons | 1 | 1986 | 9338 | 0.000 |
Why?
|